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We have modified the apparatus for isolated rat liver 
perfusion (IPRL) in order to be able to perform two 
perfusions simultaneously. In addition, we studied the 
quality and stability of livers by comparison of five dif-
ferent perfusates: Blood (Group A), Original Krebs 
Henseleit buffer (Group B), Krebs buffer with glucose 
(Group C) or bovine serum albumin (BSA) added, 
(Group D). In a last group (E) albumin, glucose, and 
taurocholic acid were added to Krebs. After 180 min of 
perfusion, livers perfused with solutions including 2% 
albumin (Group D, E) had a significantly higher release 
of hepatocellular and endothelial cell (purine nucleo-
side phosphorylase) enzymes and lower bile production 
as compared to Groups A, B, and C (P < 0.0001). In-
creasing levels of purine nucleoside phosphorylase 
(PNP), a reflection of damage to the microvascular en-
dothelium preceded the increases in hepatocellular en-
zymes. Histologically, damages of sinusoidal endothe-
lial cells and hepatocytes are appreciated moderate to 
severe in Groups D and E, slight to mild in Groups A 
and B, and not significant in Group C. These results 
suggest that BSA may have toxic effects to the perfused 
rat liver. These data also confirm that the IPRL modi-
fied for simultaneous perfusion of two livers is effi-
cient, and that with this technique the rat liver can be 
optimally perfused for up to 3 hr with oxygenated 
Krebs Henseleit buffer without additives (Group B) and 
without blood. These two improvements should allow 
those performing studies with perfused rat livers to ob-
tain data in a more efficient, accurate, and inexpensive 
fashion. 9 1992 Academic Press, Inc. 
INTRODUCTION 
Many modifications of the isolated perfused rat liver 
(IPRL) techniques have been described, but the major-
1 Dr. Hans J. Mischinger is supported by a Schroedinger Stipen-
dium for the Fond zur Foerderung der Wissenschaftlichen Forschung, 
Austria (Jo-355-Med). 
2 Dr. Thomas Walsh is a National Research Service Award Fellow 
with the National Institute of Health. 
3 To whom correspondence should be addressed at University of 
Pittsburgh, 3601 Fifth Avenue, Falk Clinic, 5 West, Pittsburgh, PA 
1521:1. 
ity of investigators have used variations of the original 
perfusion arrangement introduced by Brower and Miller 
[1-6]. At our laboratories this organ perfusion technique 
is performed to assess the viability of preserved livers 
prior to transplantation. 
To enable us to perfuse livers more efficiently, we con-
structed an IPRL apparatus designed to perfuse two 
livers simultaneously. This perfusion arrangement al-
lows more studies to be performed in less time and simul-
taneous comparisons of different treatment regimens. 
This manuscript concerns the practical aspects of this 
model as well as a study which compares stability of 
livers during perfusions with homologous blood, and 
various cell-free perfusates. The viability of hepatic en-
dothelial cells during perfusions with various perfusates 
was studied by following the release of purine nucleoside 
phosphorylase (PNP) into the perfusate. This cytoplas-
matic enzyme, most active in the endothelial and 
Kupffer cells, recently has been demonstrated to be a 
reliable index of injury to the endothelial cells after 
warm ischemia [7, 8]. Krebs-Henseleit buffer (KHB) 
with glucose, albumin, and taurocholic acid added has 
been the standard perfusate in our lab, as well as others 
[3, 5, 38]. In addition, some investigators add blood to 
KHB to improve the oxygen-carrying capacity of the 
perfusate [4, 5]. We have been interested in what the 
optimal perfusate truly is for the IPRL system, and 
whether these additives are necessary. 
MATERIALS AND METHODS 
The liver perfusion system is contained within a ther-
mostatically controlled plexiglass cabinet (65 cm Lx 32 
cm W X 60 cm H), designed to perform two perfusions 
simultaneously. Mounted within the cabinet is a frame 
that fits all clamps and holders to stabilize the various 
parts of the system (Fisher Scientific, Pittsburgh, PA). 
The perfusate is circulated by a Masterflex pump con-
troller (No.1, Fig. 1) (Cole Parmer Instrument Co., Chi-
cago, IL, Model 7553-60), which acts on silicone tubing 
(Cole Parmer Instrument Co., Models 6411-16 and 
6411-14). A separate pump is used in each of the perfu-
sion circuits. 
The oxygenator (No.2, Fig. 1) is constructed from a 
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FIG. 1. (1) Pulsatile pump. (2) Oxygenator (separated into two 
chambers). (3) Filter debubbler, upper perfusate reservoir. (4) Inflow 
perfusate sampling port, bubble trap. (5) Three-way stopcock. (6) Ma-
nometer. (7) Liver platform. (8A) Collection basin 50 cc. (8B) Collec-
tion basin, 250 cc. (9) Bile collector. (10) Constant temperature circu-
lator. (11) Digital perfusate temperature control. 
single container which has been separated into two 
chambers by fenestrated plastic wall. The same oxygen-
ator is used for both perfusion circuits. The perfusate is 
exposed to a gas mixture of 95% O2/5% CO2 while pass-
ing through a thin-walled silicone tubing (American Sci-
entist, Warrendale, PA, T5715-6, LD. 1.5 mm) which is 
8 m long. This pressurized membrane oxygenator is de-
veloped from the "Hamilton Lung" and can generate a 
partial pressure of oxygen of 500-600 mm Hg in each 
perfusion circuit at a 02/C02 flow of 5 liters/min [9, 10). 
After the oxygenator, the perfusion medium passes 
through a disposable nylon filter (blood set 64, Abbott 
Lab) (No.3, Fig. 1). The macrofilter is placed in-line 
within each inflow circuit as both a bubble trap and a 
perfusate filter. 
The pressure within each circuit is continuously mon-
itored through a three-way stop cock, placed immedi-
ately before the portal vein cannula (No.5, Fig. 1). The 
manometer (Abbott Laboratories, North Chicago, IL, 
Model 4607) (No.6, Fig. 1) is fixed to the side of the 
cabinet. 
Male Lewis rats (250 to 350 g) are used as liver donors. 
Anesthesia is induced and maintained with inhalation 
methoxyflurane. Every rat receives 300 units of heparin 
via the penile vein prior to harvest of the liver. A trans-
verse incision is made to expose the upper abdominal 
cavity, which allows optimal access to all the supporting 
ligaments of the liver and to the supra- and infrahepatic 
vena cava (lVC). For bile collection, the bile duct is intu-
bated with polyethylene (Clay Adams, PE-lO tubing, 
LD. 0.2 mm). Immediately after cannulation of the por-
tal vein with a 16-gauge teflon angiocatheter, the liver is 
flushed gently with 50-60 cc of heparinized (10 D/cc) 
Ringer Lactate solution. After cannulation of the infra-
hepatic IVC with a 14 gauge catheter, the suprahepatic 
IVC is ligated. This larger angiocatheter in the IVC re-
suIts in decreased perfusion pressures (10-15 cm H 20) at 
high flow rates (up to 3.5 cc/min/g/liver which improves 
oxygen delivery. Harvest of the second liver is staggered 
from 15 to 30 min for an adequate spacing of sample 
collection. Liver weights range from 9.37 to 12.10 g, and 
average 10.4 ± 1.3 g. 
The liver is placed on a removable petri dish (No.7, 
Fig. 1) (Fisher Scientific Corp., Pittsburgh, PA) after 
cannulation of the portal vein and IVC is completed. 
Grooves at the edge of the dishes stabilize the portal and 
IVC cannulae. The IVC effluent drains into a dispos-
able, 50-cc centrifuge tube (No. 8A, Fig. 1) (Corning Lab-
oratory Sciences Co., Corning, NY) which is attached to 
a second petri dish. If the perfusate will be sampled fre-
quently, a larger reservoir (250-cc centrifuge tube) can 
be substituted (No. 8B, Fig. 1). 
The temperature of the perfusate is maintained at 
37°C [11] by a circulating water bath in the base of the 
cabinet (No.9, Fig. 1). Each system is continuously 
monitored with a digital thermometer and a thermistor 
in the arterial inflow (Type T thermo couple thermome-
ter, Cole Parmer Instrument Co.) (No. 11, Fig. 1). 
Perfusates. The standard perfusate in our experi-
ments used (Table 1) is based upon the original Krebs-
Henseleit solution (Group B) (12). In Group A, we em-
ployed homologous whole rat blood diluted with KHB to 
a hematocrit value of 15-20% with a osmolarity ranging 
between 295-302 milliosmols (mosmol). In Group C, the 
livers were perfused with Krebs plus 5.5 mM glucose 
added as an energy source. Krebs buffer with 2% BSA 
added as an oncotic agent (Albumin, Fraction V, Sigma 
Chemical Co) was used in Group D. As anginous modi-
fied Krebs solution, which is commonly used in many 
laboratories, contains albumin (2%), glucose (5.5 mM), 
and taurocholic acid (0.073 g/liter). This perfusate was 
studied in Group E (3, 13, 14). The volume of medium 
used in each perfusion system was 180 ml. A separate 
group (F) was subjected to 90 min of warm ischemia via 
bypassing perfusate flow around the liver to show the 
effects of severe injury. This period of ischemia was fol-
lowed by 120 min of reperfusion with KHB. 
TABLE 1 
Perfusates Used in Experimental Groups A-E 
A B C D E F 
Krebs + + + + + + 
5.5 mM Glucose + + 
2% Albumin + + 
Taurocholic acid + 
Blood + 
Note. The Krebs medium consisted of NaC1118.5 mM, KCI4. 7 mM, 
CaCL2 H 20 2.5 mM, KH2 P04 1.2 mM, MgS04 1.2 mM, NaHCOs 24.9 
mM. Livers were flushed with Ringer's solution and immediately 
placed on the perfusion apparatus. In Group F the livers were sub-
jected to 90 min of warm ischemia (bypass ischemia). 
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TABLE 2 
Comparison of Perfusions in IPRL Using Different Perfusates (A-F) 
Flow rate 
(ml/g liver/min) 
Portal vein pressure 
(em H 20) 
Oxygen consumption 
(nmol/g liver/min) 
Time course 
60 min 
120 min 
180 min 
Mean 
Osmolarity 
(mosmole) 
A 
2.2 
10.1 ± 0.8 
2.87 ± 0.4 
2.25 ± 0.07 
2.05 ± 0.07 
2.51 ± 0.51 
300 ± 4.4 
B 
3.0 
8.4 ± 2.0 
1.31 ± 0.1 
1.41 ± 0.0 
1.12 ± 0.01 
1.28 ± 0.13 
287 ± 4.0 
C D E 
3.0 3.0 2.3 
9.9 ± 1.1 10.9 ± 1.0 8.73 ± 1.3 
1.41 ± 0.09 1.78 ± 0.04 1.42 ± 0.06 
1.63 ± 0.09 1.72 ± 0.04 1.48 ± 0.01 
1.67 ± 0.02 1.60 ± 0.14 1.55 ± 0.04 
1.52 ± 0.1 1.70 ± 0.13 1.47 ± 0.07 
306 ± 7.6 296 ± 3.0 297 ± 9.0 
Note. The experimental conditions were described under Materials and Methods. The values are means ± SD. 
Monitoring of liver function. All perfusions in 
Groups A-E were done for 3 hr after an initial equilibra-
tion period of 15 min (t - 15). The samples were taken at 
t - 15, to, and subsequently every 30 min during the 3-hr 
perfusion period. Six liver perfusions were performed in 
each group. 
(A) The oxygen consumption of the liver was moni-
tored by periodic determination (15 min) of the p02 and 
pC02 (mm Hg) of the portal vein inflow (PV) and lVC 
outflow using a pH-blood gas meter (ABL 2-Acid-Base 
Laboratory, Radiometer, Copenhagen, Denmark) (4). 
The oxygen consumption (02/g wet liver/min) was cal-
culated by 
PV O2 content - lVC O2 content 
100 X W (liver) 
X flow (mljmin) X 44.6. 
4 
o~ __ -L ____ L-__ -L ____ L-__ -L ____ ~ __ ~ __ ___ 
o 15 SO 60 90 120 150 180 
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FIG. 2. Effects of different perfusates on oxygen consumption 
using the IPRL. The experimental conditions and calculation of oxy-
gen consumption were as described under Materials and Methods. In 
contrast to Group A, Groups B-E maintained stable consumption of 
oxygen and showed no differences throughout the perfusion period (P 
> 0.0001). 
(B) All bile (microliter/g liver/min) secreted was col-
lected into a graduate cylinder (No. 10, Fig. 1) and quan-
titated every 15 min. 
(C) The release of hepatocellular enzymes (AST, 
AL T, and LDH) into the perfusate were determined us-
ing a Technicon RA-500 analyzer. 
(D) Levels of (PNP) in the effluent were measured 
using the methods of Hoffee et al. (15). The increase in 
absorbance (293 nm) from uric acid produced by the 
breakdown of nucleoside was measured by a coupled 
spectrophotometric assay. 
Histopathology. After a 3 hr perfusion, each liver 
specimen was fixed in 10% neutral buffered formalin 
and routinely stained with hematoxylin and eosin. 
Histological evaluation was blindly and indepen-
dently assessed for each specimen by one of the authors 
(K.N.). The histological features of the hepatic damage 
of the liver tissue examined were morphological changes 
of sinusoidal lining cells and hepatocytes as a whole, and 
graded from 0 to 4 with 0, indication nothing particular; 
1, slight; 2, mild; 3, moderate; and 4, severe changes. 
Statistical analysis. Data are presented as mean ± 
standard deviation (M ± SD). In order to investigate 
differences between the groups, a repeated measures 
analysis of variance was performed. The three hypothe-
ses of interest were: (1) between group differences, (2) 
within time difference, and (3) the interaction between 
time and groups [16-18]. When indicated, the student's t 
test was performed. 
RESULTS 
Hemodynamic parameters. The rate of perfusate 
flow with cell-free perfusates and with the blood con-
taining medium ranged from 2.3 to 3 mljg liver/min 
which resulted in a perfusion pressure between 8.4 ± 2.0 
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FIG. 3. (a) Bile flow during a 1S0-min perfusion period. Each bar represent microliter bile per wet weight liver produced per min. A 
significantly greater bile flow (P < 0.0001) was seen in the groups without albumin (BSA) added to the perfusate. (b) The cumulative bile 
production during a ISO-min perfusion. The excreted bile in Groups D and E was significantly less than that in Groups A-C (P < 0.0001). No 
statistical difference was seen between Groups D and E (P = 0.S5:». 
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(Table 2) in groups without blood was 1.5 ± 0.2 02/g 
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2.57 ± 0.5 mol Oz/g liver/min (P < 0.0001) when com-
pared to the blood free perfusions (Fig. 2). After 180 min, 
the oxygen uptake in this group declined from 2.87 ± 0.4 
to 2.05 nmole/g liver/min (29%). In livers perfused 
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FIG. 4. (a-c) Enzyme release (AST, ALT, LDH) during the 3-hr perfusion period. In the perfusions with albumin (Groups D, E) the 
hepatocellular enzymes significantly (P < 0.0001) rose especially after the second hour of perfusion. (d) PNP levels in perfusions with albumin 
of blood were significantly higher (P < 0.0001). There was no significant difference between groups including albumen in the perfusate (P ~ 
0.569). Also no significant P value could be seen in blood perfusates compared to the later groups (D, E) over the ISO-min perfusion period. 
Higher hepatocellular enzymes and PNP levels using blood (Group A) coincide with progressive hemolysis. Dotted line (Group F) represents 
changes in PNP levels during reperfusions after 90 min of warm ischemia. 
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FIG. 5. Comparison of bile flow (microliter/g liver/min) and 
PNP (U/liter) release in a perfusion using albumin (Group E). A sig-
nificant correlation (Spearman rank, r = -0.738, P < 0.05) was ob-
served between increase in the activity of PNP in the perfusate and 
decreasing bile flow. 
without blood oxygen consumption averaged 1.51 ± 0.18 
nmole/g liver/min and remained stable throughout the 
perfusions. 
Bile flow. The volume of excreted bile was signifi-
cantly lower in perfusions using albumin (P < 0.0001) 
(Fig. 3A). In Groups D and E, bile flow averaged 0.51 ± 
0.13 and 0.46 ± 0.19 Illig/min, respectively, which were 
significantly lower than the bile flow in all other groups 
(P < 0.0001). The livers perfused with Krebs solution 
either without glucose or with glucose only added 
(Group B, C) had bile flow comparable to that of livers 
perfused with blood. The cumulative bile production is 
also greater in those livers perfused without albumin (P 
< 0.0001) (Fig. 3B). 
pH. The pH of the perfusate fell slightly in all groups 
from 7.40 to 7.32 over the 3-hr period (data not shown). 
Enzyme activity. The release of hepatocellular en-
zymes (AST, ALT, LDH) was significantly elevated in 
perfusions containing albumin (Group D and E). The 
leakage of hepatocellular enzymes started between 90 
and 120 min as compared to Groups Band C which 
showed no increase in AST, ALT, and LDH (Figs. 4A-
4C). Throughout the perfusion with blood, enzyme lev-
els were higher presumably due to hemolysis of red cells. 
The most sensitive indicator of a failing perfusion was 
an increase in LDH activity, as the perfusions with albu-
min, showed an exponential rise after 90 min. 
The release of PNP (Fig. 4D) was high in perfusates 
containing blood and cell-free perfusates with albumin. 
Only a mild activity was seen in the Groups Band C 
(without BSA) as PNP activity averaged 10.1 ± 3.5 and 
7.1 ± 4.9 at the end of 180 min of perfusion. These were 
significantly lower than in Groups A (74 ± 21.3) and E 
(46 ± 7.08) (P < 0.0001). 
In Group A, there was a gradual accumulation of PNP 
in the perfusate, while the livers perfused with albumin 
showed high levels of PNP early which were sustained 
throughout the perfusion. In livers subjected to 90 min 
warm ischemia, levels of PNP rose to 132 ± 22.5 m U Iml 
by the end of the ischemic period. After an initial de-
crease during the early reperfusion PNP levels steadily 
increased throughout reperfusion (P < 0.0001) (Fig.4D) . 
In those livers showing gradual damage during a perfu-
sion (D, E) the degree of PNP release correlated with 
reduced bile production (Fig. 5). In addition, the leakage 
of PNP preceded the increase of hepatocellular enzymes 
(Figs 4A-4D). 
Histopathology. Sinusoidal lining cells are normally 
seen with slender and fusiform configuration, attached 
to the regularly arranged cords of hepatocytes (Fig. 6a). 
Slightly to mildly damaged (Fig. 6b), they appeared 
round and denudated in configuration, and detached 
from the cords. Moderately to severely damaged (Figs. 
6c, 6d), sinusoidal lumen laced the lining endothelial 
cells but filled with sloughs of nuclear debris. 
Damage of the hepatocytes was evaluated by focal and 
spotty necrosis, intracytoplasmic vacuolization, and ir-
regular arrangement of cords. Severely damaged hepatic 
tissue often showed patchy areas ofhepatocytic discolor-
ation preferentially located in the centrilobular area ac-
companied by lender cords of hepatocytes with eosino-
philic cytoplasm and pyknotic nuclei consistent with his-
tological changes of ongoing necrosis. 
As shown in Table 3, histological damages were most 
evident in Groups D and E, while Groups A and C re-
tained near-normal architecture after 3 hr perfusion. 
DISCUSSION 
Various modifications of the IPRL technique have 
been reported, and a variety ofperfusates are used (1-6). 
This makes comparison and reproduction of results 
from different laboratories difficult. Since the apparatus 
is so extensively used in biochemical and clinical studies, 
we set out to make IPRL more efficient and to standard-
ize the technique. The first effort was to develop a sys-
tem for simultaneous perfusion of two livers. The second 
goal was to systematically study various perfusates 
under identical conditions by comparing organ viability 
based on patterns of bile flow and production, leakage of 
hepatocellular enzymes and of PNP as a marker of endo-
thelial integrity [7]. 
In the initial experiments, we compared KHB and a 
perfusate containing homologous blood. The addition of 
blood to perfusates is used by many investigators but is 
controversial because of the effect of inconstant levels of 
hematocrit on hepatic function. In addition, organ func-
tion is adversely affected by hemolysis and microemboli 
[10,20,21]. We found no difference as to the rate of bile 
flow or cumulative bile production between perfusions 
performed with (Group A) and without blood (Group B). 
The absence of blood allowed for more stable and lower 
enzyme levels in perfusate. The unpredictable effects of 
factors soluble in blood (hormones, immunoglobulins, 
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FIG. 6. Histological grades of hepatic damage. (a) Not particular (Group A; H&E, X500). (b) Slight damage (Group B; H&E, X500). (c) 
Moderate damage (Group E; H&E, x500). (d) Severe damage (Group E; H&E, x500). 
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TABLE 3 
The Degree of Histological Damage of the Liver 
After a 3-hr Perfusion 
(N) Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 
Group A 5 3 2 0 0 0 
Group B 7 1 3 1 1 1 
Group C 4 4 0 0 0 0 
Group D 6 0 3 2 1 0 
Group E 10 0 0 3 5 2 
Note. Grades from 0 to 4 were described under Material and Meth-
ods. 
etc.) are eliminated when blood-free perfusates are used. 
Finally, the sacrifice of animals for blood is obviated. 
The flow rate was kept at 3.0 mljg liver/min in blood-
free perfusions, and between 2 to 2.3 ml/g liver in blood 
containing perfusions. A higher flow rate of 3 mljg liver 
was the required oxygenation when perfusates without 
blood were used. We were able to accomplish this while 
keeping the portal pressure in the physiological range of 
8.4 ± 2.0 to 10.9 ± 1.0 mM Hg [22, 23]. This perfusion 
pressure is necessary to deliver sufficient oxygen to the 
liver while avoiding barotrauma to the sinusoidal endo-
thelial cells [3, 5, 24]. Oxygen consumption with homolo-
gous blood was nearly twice that of the cell-free perfu-
sions, but gradually declined throughout the perfusion 
consistent with a decline in the viability of erythrocytes 
[25]. The stability of oxygen consumption in the perfu-
sions without blood oxygen argues against the liver be-
ing compromised by the absence of erythrocytes. The 
higher flow rates compensated well for the lower oxy-
gen-carrying capacity of cell-free perfusates. 
The exclusion of albumin from the cell-free perfusates 
proved to be a critical improvement in the technique. 
Hepatic function was more stable as judged by constant 
enzyme levels and bile production. The leakage of hepa-
tocellular enzymes in these perfusions were also consid-
erably less than in other reports using cell-free or blood-
containing perfusates [26, 27]. These findings may be 
related to a toxic effect of bovine albumin on the rat 
liver. In a model of kidney preservation, denaturation of 
BSA was shown to occur with the production of harmful 
substances which lead to severe organ damage [28, 29]. 
Hepatocellular enzymes can be released in toxic and met-
abolic injuries even in the absence of fulminant hepatic 
necrosis through shedding from viable hepatocytes of 
cytosol contained within cell-surface blebs [30]. The co-
incident decreasing bile production supports the theory 
that the livers are being damaged duringperfusions with 
albumin. 
Histochemical studies have shown that PNP is an en-
zyme most active in the cytoplasm of endothelial and 
Kupfl'er cells (7). A correlation had been demonstrated 
between levels of PNP and the degree of microvascular 
endothelial cell damage after warm ischemia and reper-
fusion (8). This observation was also confirmed in this 
study in the perfusions following a 90-min period of 
warm ischemia. The degree ofPNP release was compara-
ble in the ischemic and blood containing perfusions 
(Groups F and A). Release of PNP was lower in the per-
fusions without albumin (P < 0.0001). The higher levels 
of transaminases and PNP in the perfusate using blood 
coincide with progressive hemolysis and blockage of the 
microvasculature. Leakage of enzymes from erythro-
cytes clouds the results of any perfusion, and the pres-
ence of erythrocytes did not yield higher or more con-
stant bile productions (P = 0.404). 
Our results show that an oncotic agent is not essential 
for successful isolated perfusion of the rat liver over a 
period of 3 hr. The rise in PNP routinely preceded the 
increase in AST, ALT, and LDH, which may reflect an 
initial endothelial cell injury with a secondary damage to 
the hepatocytes (Figs. 4A-4D). The relationship be-
tween endothelial injury and liver failure is confirmed by 
the correlation between decreasing bile production and 
increasing PNP release into the perfusate (Fig. 5). 
Some reports have mentioned that bile production 
may be a less reliable parameter of liver function than 
the composition of secreted bile because of exposure to 
many factors, namely nervous, humoral, and ionic [31]. 
Sufficient bile production in our system was obtained 
without the continuous replacement of bile acids. This 
production was comparable to that reported by other 
authors, [3,4, 14,32,33]. In standard IPRL systems, a 
gradual drop in bile production of up to 40% is expected 
after 2 hr of perfusion [34]. However, after an initial rise 
during the first 30 min of perfusions, the amount of bile 
produced during perfusions without albumin was stable 
and significantly higher than in the presence of albumin 
(P < 0.0001). In our system, the extent of hepatic injury 
can be assessed simply by monitoring the bile flow rate 
as a reflection of the cellular energy status [35-37]. 
In the past, isolated perfusion of organs has been a 
time-consuming procedure. However, we have further 
modified this technique so as to be able to efficiently 
perfuse two livers simultaneously. Simple KHB seemed 
to be the optimal perfusate and the addition of erythro-
cytes, glucose, albumin, and bile acids is unnecessary 
and potentially damaging. This model can be easily as-
sembled from common laboratory supplies, and may al-
low less expensive, and more economical use of perfused 
organs in a variety of research fields [38]. 
ACKNOWLEDGMENTS 
We express our appreciation to F. Sterz, M.D., R. E. Stauber, M.D., 
and Jo Smerdell for their assistance in processing the data and to 
Bernice Kula for typing the manuscript. 
REFERENCES 
1. Miller, L. L., Bly C. G., Watson, M. L. and Bale, W. F. The 
dominate role of the liver plasma protein synthesis. J. Exp. Med. 
94: 431, 1951. 
MISCHINGER ET AL.: ISOLATED PERFUSION OF RAT LIVERS AND EVALUATION OF PERFUSATES 165 
2. Miller, L. L. History of isolated liver perfusion and some still 
unsolved problems. In 1. Bartosek, A. Guaitini, and L. L. Miller, 
(Eds.), IsoLated Liver Perfusion and Its Applications. New York: 
Raven Press, 1972, pp. 1-9. 
3. Gores, G. J., Kost, L. J., and Larusso, N. F. The isolated perfused 
rat liver: Conception and protocol considerations. Hepatology 
6(3): 511, 1986. 
4. Ross, B. Perfusion Techniques in Biochemistry. Oxford: Clare-
don Press, 1972. 
5. Wolkoff, A. W., ,Johansen, K L., and Goeser T. The isolated 
perfused rat. liver: Preparation and application. Anal. Bio. Chem. 
167: 1, 1987. 
6. Gayle, W. E. Isolated organ perfusion: Physiology and applica-
tion. Med. Coli. Va. Q. 5: 1773, 1969. 
7. Rubio R., and Berne, R. Localization of purine and pyrimidine 
nucleoside phosphorylases in heart, kidney, and liver. Am. J. 
Physiology 239: H721, 1980. 
8. Rao P. N., Walsh, T. R., Makowka, L., Rubin, R., Weber, '1'., 
Snyder, J. T., and Starzl, T. E. Purine nucleoside phosphorylase 
(PNP)-A new marker for free oxygen radical injury to endothe-
lial cell. Hepatologv, in press. 
9. Hamilton, R. L., Berry M. N., Williams, M. L., and Severing-
haus, E. M. A simple and inexpensive membrane "lung" for 
small organ perfusion. J. Lipid Res. 15: 182, 1974. 
10. Melrose, D. G., Burns, N., Singh, M. P., Elliot, R., Read, R., 
Williams, F. E., Becket, J., Lamp, M. P., and Adams, ,J. S. Oscil-
lating silicone membrane tubes: A new principle of extracorporal 
respiration. Biomed. Eng. 7: 60, 1972. 
11. Skibba, ,J. L., and Collins, F. G. Effect of temperature on bio-
chemical functions in the isolated perfused rat liver. J. Surg. Res. 
24: 435, 1978. 
12. Krebs, H. A., and Henseleit, K. Untersuchungen uber die Harn-
stofthildung im Tierkorper. Hoppe-SeyLer's Z. Physiol. Chem. 
210: 33, 1932. 
13. Rosini, S., Bennetti, D., and Kvetina J. The functional capacity 
of the isolated perfused rat liver in relation to the colloidal os-
motic composition of the perfusion medium. Farmac. Prato 31: 
625, 1976. 
14. Schmucker, D. L., Jones, A. L., and Michielsen, C. E. An im-
proved system for hemoglobin free perfusion of isolated rat 
livers. Lab. Invest. 33: 168, 1975. 
15. Hoffee, P. A., May, R., and Robertson, B. C. Purine nucleoside 
phosphorylase from salmonella thyphimurium and rat liver. In 
P. Hoffe and M. A. Jones (Eds.), Methods in enzymology. New 
York: Academic Press, 1978, Vol. 51, pp. 517-524. 
16. Bock, R. D. Multivariated Statistical Methods in Behavioral Re-
search. New York: McGraw-Hill, 1975. 
17. Collier, R. 0., Baker, F. B., Mandeville, G. K, and Hayes, T. F. 
Est.imates of test size for several test procedures based on conven-
tional variance ratios in the repeated measures design. Psycho-
metrilw 32(3): 339, 1967. 
18. Davidson, M. L. Univariate versus multivariate tests in re-
peat.ed-measures. Psyeholog. Bull. 77(96): 446, 1972. 
19. Ashmore, P. G., Svitek, V., and Ambrose, P. The incidence and 
effects of particulate aggregation and microembolism in pump 
oxygenator systems. J. Thorae. Cardiovase. Surg. 55: 691, 1968. 
20. Felts, ,/. M. The metabolism of chylomicron triglyceride fatty 
acids by perfused rat livers and by intact rat.s. Ann. NY. Acad. 
Sci. 131: 24, 1965. 
21. Riedel, G. L., Scholle ,J. L., Shepherd, A. P., and Ward, W. F. 
Effects of hematocrit on oxygenation of the isolated perfused rat. 
liver. Am J. Physiol. 245: 769, 1983. 
22. Bartosek, I., Guaitani, A., and Miller, L. L. Isolated Liver Perfu-
sion and Its Applications. New York: Raven Press, 1973. 
2a. Fraser, R., Bowler, L. M., Day, W. A., et al. High perfusion pres-
sure damages the sieving ability of sinusoidal endothelium in rat 
livers. Br. J. Exp. Pathol. 61: 222, 1980. 
24. Schmucker, D. L., and Curt.is, J. C. A correlated study of fine 
struct.ure and physiology of the perfused rat liver. Lab. Invest. 
30: 201, 1974. 
25. Schimassek, H. Perfusion of isolated rat liver with semisynthetic 
medium and control of liver function. Life Sci. 11: 629, 1962. 
26. Schmidt, E., Schmidt, F. W., Mohr, J., Otto, P., Vido, 1., Wroge-
mann, K., and Herfarth, C. M. Liver morphology and enzyme 
release: Further studies in t.he isolated perfused rat liver. In 
Keppler, D. (Ed.), Pathogenesis and Mechanisms of Liver Cell 
Necrosis. Baltimore: University Park Press, 1975. pp. 147-162. 
27. Erikson, H. A compact perfusion syst.em for studies on the con-
trol of metabolic processes in isolated organs from small animals. 
Acta. Ph:l'siol. Scand. 93: 206, 1975. 
28. Southard, ,J. H., Sen zig, K A., Hoffman, R., and Belzer, F. 0.: 
Denaturation of albumin: A critical factor in long term kidney 
preservation. J. Surg. Res. 30: 80, 1981. 
29. Cohen, R., Ues, R., and Lloyd, M. Perfusion of the isolated rat 
liver. In H. Ritchie and J. Hardcastle (Eds.), Isolated Organ Per-
fusion. Baltimore, London, Tokyo: University Park Press, 1973. 
p.120. 
30. Lemasters, J. J., Stemkowski, C. J., Ji, S., and Thurman, R. G. 
Cell surface changes and enzyme release during hypoxia and 
reoxygenation in the isolated, perfused rat liver. J. Cell BioI. 97: 
778, 1983. 
:n. Boyer, ,J. L., Scheig, R. L., and Klatskin, G. The effect of sodium 
taurocholat.e on the hepatic metabolism of sulfobromophat.ha-
lein sodium (BSP). The role of the bile How. J. Clin. Invest. 49: 
206,1970. 
32. Tavolini, N., Reed, S., Boyer, J. L. Hemodynamic eft'ects on de-
terminant.s of bile determinants in isolated rat liver. Am. J. Phys-
iol. 234: 584, 1978. 
33. Sugano, T., Suda, K, Shimada, M., and Oshimo, N. Biochemical 
and ultrastructural evaluat.ion of isolated rat liver systems per-
fused with hemoglobin free medium. J. Biochem. 83: 995, 1978. 
:34. Meijer, D. K., Keulemans, K., and Mulder, G. J. Isolated per-
fused rat liver technique. In W. B. Jakoby (Ed.), Methods in En-
zymology. San Diego: Academic Press, 1981. Vol. 77, pp. 81. 
35. Nakazawa, T., and Nunokawa, T. Energy transduction and ade-
nine nucleotides in mitochondria from rat liver after hypoxic 
perfusion. J. Biochem. 82: 1575,1977. 
36. Watanabe, F., Kamiikie, W., Nishimura, T., Hashimot.o, T., and 
Tagawa, K. Decrease in mitochondrial levels of adenine nucleo-
tides and concomitant mitochondrial dysfunction in ischemic rat 
liver. J. Biochem. 94: 483, 198a. 
:37. Kamiikie, W., Nakahara, M., Nakao, K., Koseki, M., Nishida, 
T., Kawashima, T., Watanabe, F., and Tagawa, K. Correlation 
between cellular ATP level and bile excret.ion in t.he rat liver. 
Transplantation 39: 50, 1985. 
38. Ontell, S. ,J., Collella, M. S., Horowitz, J., Makowka, L., Trager, 
,J., and Starzl, T. E. Applications oft.he isolated perfused rat liver 
in transplant. research. J. Invest. Surg. 1: 25, 1988. 
